Aspect Partners
IMMX icon

Aspect Partners’s Immix Biopharma IMMX Stock Holding History

Aspect Partners’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11K Buy
107
+19
+22% +$215 ﹤0.01% 575
2026
Q2 		$907 Buy
88
+79
+878% +$733 ﹤0.01% 584
2026
Q1 		$82 Buy
+9
New +$66 ﹤0.01% 702

Other funds holding IMMX

Prosperity Capital Advisors
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 15.9% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Aspect Partners's IMMX Position: Q3 2026 in Review

Aspect Partners increased its Immix Biopharma (IMMX) stake by 22% in Q3 2026, buying an estimated $215 and bringing the position to 107 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Aspect Partners first reported a position in IMMX in Q1 2026 and has held it in 3 quarters since. 11 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Aspect Partners held 107 shares of Immix Biopharma worth $1.11K as of Q3 2026.
  • Aspect Partners bought 19 Immix Biopharma shares in Q3 2026, an estimated $215.
  • Immix Biopharma made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #575 holding.
  • Aspect Partners first reported a position in Immix Biopharma in Q1 2026 and has held it in 3 quarters since.
  • 11 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.